Search research articles
Contact Us
Filters
Showing results (131-140 of 141) with videos related to
Page
of 15
Sort By:
Journal of Neuroscience Methods
|
November 7, 2006
A high throughput fluorescent assay for measuring the activity of fatty acid amide hydrolase
Karen L Kage, Paul L Richardson, Linda Traphagen, et al.
Pilot and Feasibility Studies
|
July 19, 2022
Online singing interventions for postnatal depression in times of social isolation: a feasibility study protocol for the SHAPER-PNDO single-arm trial
Rebecca H Bind, Carolina Estevao, Daisy Fancourt, et al.
Cerebrovascular Diseases (Basel, Switzerland)
|
February 27, 2024
Late Lesion Growth following Endovascular Therapy: Is 24 h Too Early to Assess Acute Infarct Size Including the Effects of Secondary Injury?
Marie Luby, Amie W Hsia, Carolyn A Lomahan, et al.
Pilot and Feasibility Studies
|
July 27, 2023
Feasibility, clinical efficacy, and well-being outcomes of an online singing intervention for postnatal depression in the UK: SHAPER-PNDO, a single-arm clinical trial
Rebecca H Bind, Kristi Sawyer, Katie Hazelgrove, et al.
Journal of Medicinal Chemistry
|
December 28, 2002
Synthesis and structure-activity relationships of 6,7-disubstituted 4-anilinoquinoline-3-carbonitriles. The design of an orally active, irreversible inhibitor of the tyrosine kinase activity of the epidermal growth factor receptor (EGFR) and the human epidermal growth factor receptor-2 (HER-2)
Allan Wissner, Elsebe Overbeek, Marvin F Reich, et al.
British Journal of Pharmacology
|
August 11, 2004
In vitro and in vivo characterization of a novel naphthylamide ATP-sensitive K+ channel opener, A-151892
Murali Gopalakrishnan, Steven A Buckner, Char-Chang Shieh, et al.
BMC Family Practice
|
December 18, 2013
Primary care and youth mental health in Ireland: qualitative study in deprived urban areas
Dorothy Leahy, Elisabeth Schaffalitzky, Claire Armstrong, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 18, 2002
(-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637): a novel ATP-sensitive potassium channel opener efficacious in suppressing urinary bladder contractions. I. In vitro characterization
Murali Gopalakrishnan, Steven A Buckner, Kristi L Whiteaker, et al.
Frontiers in Health Services
|
July 21, 2025
Implementation of singing groups for postnatal depression: experiences of participants and professional stakeholders in the SHAPER-PND randomised controlled trial
Emeline Han, Rachel Davis, Tayana Soukup, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
October 14, 2025
Clinical effectiveness, implementation effectiveness and cost-effectiveness of a community singing intervention for postnatal depressive symptoms, SHAPER-PND: randomised controlled trial
Rebecca H Bind, Andrew J Lawrence, Carolina Estevao, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 141) with videos related to
Sort By:
Page
of 15
Journal of Neuroscience Methods
|
November 7, 2006
A high throughput fluorescent assay for measuring the activity of fatty acid amide hydrolase
Karen L Kage, Paul L Richardson, Linda Traphagen, et al.
Pilot and Feasibility Studies
|
July 19, 2022
Online singing interventions for postnatal depression in times of social isolation: a feasibility study protocol for the SHAPER-PNDO single-arm trial
Rebecca H Bind, Carolina Estevao, Daisy Fancourt, et al.
Cerebrovascular Diseases (Basel, Switzerland)
|
February 27, 2024
Late Lesion Growth following Endovascular Therapy: Is 24 h Too Early to Assess Acute Infarct Size Including the Effects of Secondary Injury?
Marie Luby, Amie W Hsia, Carolyn A Lomahan, et al.
Pilot and Feasibility Studies
|
July 27, 2023
Feasibility, clinical efficacy, and well-being outcomes of an online singing intervention for postnatal depression in the UK: SHAPER-PNDO, a single-arm clinical trial
Rebecca H Bind, Kristi Sawyer, Katie Hazelgrove, et al.
Journal of Medicinal Chemistry
|
December 28, 2002
Synthesis and structure-activity relationships of 6,7-disubstituted 4-anilinoquinoline-3-carbonitriles. The design of an orally active, irreversible inhibitor of the tyrosine kinase activity of the epidermal growth factor receptor (EGFR) and the human epidermal growth factor receptor-2 (HER-2)
Allan Wissner, Elsebe Overbeek, Marvin F Reich, et al.
British Journal of Pharmacology
|
August 11, 2004
In vitro and in vivo characterization of a novel naphthylamide ATP-sensitive K+ channel opener, A-151892
Murali Gopalakrishnan, Steven A Buckner, Char-Chang Shieh, et al.
BMC Family Practice
|
December 18, 2013
Primary care and youth mental health in Ireland: qualitative study in deprived urban areas
Dorothy Leahy, Elisabeth Schaffalitzky, Claire Armstrong, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 18, 2002
(-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637): a novel ATP-sensitive potassium channel opener efficacious in suppressing urinary bladder contractions. I. In vitro characterization
Murali Gopalakrishnan, Steven A Buckner, Kristi L Whiteaker, et al.
Frontiers in Health Services
|
July 21, 2025
Implementation of singing groups for postnatal depression: experiences of participants and professional stakeholders in the SHAPER-PND randomised controlled trial
Emeline Han, Rachel Davis, Tayana Soukup, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
October 14, 2025
Clinical effectiveness, implementation effectiveness and cost-effectiveness of a community singing intervention for postnatal depressive symptoms, SHAPER-PND: randomised controlled trial
Rebecca H Bind, Andrew J Lawrence, Carolina Estevao, et al.
Page
of 15